Company intelligence / Profile preview

ORI Healthcare Fund

Wanchai, Hong Kong

Ownership: Private
Development stage: Other

Overview

ORI Capital is a venture capital firm focused on healthcare investments. It manages funds including ORI Healthcare Fund and ORI Healthcare Fund II, investing in early-stage biotech companies across therapeutic areas like cancer, cardiovascular, and neurodegenerative diseases, leveraging technologies such as small molecules, cell therapy, and AI-driven platforms.

Modalities: Small MoleculesProgrammable Nucleic Acid TherapiesImmuno-oncologyCell TherapySynthetic BiologyProtein DegradersRNA Therapies
Industry: Investors

Beyond the preview

Go deeper on ORI Healthcare Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ORI Healthcare Fund.

Explore the full profile